Health Care [ 8/12 ] | Life Sciences Tools & Services [ 66/73 ]
NASDAQ | Common Stock
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.
It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services.
In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials.
Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jul 21, 25 | 3.10 Increased by +12.84% | 2.99 Increased by +3.78% |
| Apr 21, 25 | 3.67 Increased by +14.69% | 3.08 Increased by +19.25% |
| Feb 10, 25 | 3.68 Increased by +49.65% | 3.12 Increased by +18.12% |
| Oct 21, 24 | 3.01 Increased by +35.59% | 2.78 Increased by +8.27% |
| Jul 22, 24 | 2.75 Increased by +42.49% | 2.54 Increased by +8.27% |
| Apr 22, 24 | 3.20 Increased by +40.97% | 2.47 Increased by +29.55% |
| Feb 12, 24 | 2.46 Increased by +16.04% | 2.22 Increased by +10.81% |
| Oct 23, 23 | 2.22 Increased by +8.29% | 2.05 Increased by +8.29% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 603.31 M Increased by +14.24% | 90.26 M Increased by +2.16% | Increased by +14.96% Decreased by -10.57% |
| Mar 31, 25 | 558.57 M Increased by +9.30% | 114.59 M Increased by +11.70% | Increased by +20.52% Increased by +2.20% |
| Dec 31, 24 | 536.59 M Increased by +7.66% | 117.02 M Increased by +49.45% | Increased by +21.81% Increased by +38.82% |
| Sep 30, 24 | 533.32 M Increased by +8.29% | 96.43 M Increased by +36.68% | Increased by +18.08% Increased by +26.22% |
| Jun 30, 24 | 528.10 M Increased by +14.59% | 88.35 M Increased by +44.68% | Increased by +16.73% Increased by +26.26% |
| Mar 31, 24 | 511.04 M Increased by +17.73% | 102.59 M Increased by +40.74% | Increased by +20.07% Increased by +19.54% |
| Dec 31, 23 | 498.40 M Increased by +26.47% | 78.30 M Increased by +14.02% | Increased by +15.71% Decreased by -9.84% |
| Sep 30, 23 | 492.50 M Increased by +28.34% | 70.55 M Increased by +6.85% | Increased by +14.32% Decreased by -16.74% |